
EPS HEALTH TECH plans to acquire a controlling stake in a company primarily engaged in the manufacturing and sales of pharmaceuticals

According to the Zhitong Finance APP, EPS HEALTH TECH announced that the company is in preliminary discussions with its controlling shareholder and other parties regarding the group's proposed acquisition of a controlling stake in a company. The company is registered in the People's Republic of China and primarily engages in the manufacturing and sales of pharmaceuticals, which aligns with the group's existing business. No terms have been agreed upon regarding the proposed acquisition, nor have any formal or informal agreements been established
According to the Zhitong Finance APP, EPS HEALTH TECH (03860) announced that the company is in preliminary discussions with its controlling shareholder and other parties regarding the group's proposed acquisition of a controlling stake in a company. The company is registered in the People's Republic of China and primarily engages in the manufacturing and sales of pharmaceuticals, which aligns with the group's existing business. No terms have been agreed upon regarding the proposed acquisition, nor have any formal or informal agreements been established

